Bowel Cancer Screening Stratified by Risk Summary Screening for bowel cancer using FIT (Faecal Immunochemical Test) has been successful in saving lives in the UK – but it could save more lives by making better use of the test. There are moves towards ‘risk-based screening’; this can increase the identification through screening of those who are most likely to be at high risk of bowel cancer. So instead of the FIT producing a ‘yes-no’ answer, the study will use its whole range of values in deciding what further tests (if any) are needed. The study will examine other factors risk factors and see how they might lead to further improvements in screening performance and patient outcomes. The acceptability of these approaches to the UK general public will be explored. The impact on the running of the NHS screening programmes will be measured – how much these alternative approaches might cost, and impact on health inequalities. Key People NameRoleInstitutionDavid WellerChief Investigator (Lead)University of EdinburghPeter SasieniCo-Investigator (Co-Lead)Queen Mary University of LondonChristine CampbellCo-InvestigatorUniversity of EdinburghMalcolm DunlopCo-InvestigatorUniversity of EdinburghRichard HoulstonCo-InvestigatorUniversity of EdinburghStephen DuffyCo-InvestigatorQueen Mary University of LondonRhian Gabe Co-InvestigatorQueen Mary University of LondonSophie Whyte Co-InvestigatorUniversity of SheffieldChrisitan von WagnerCo-InvestigatorUniversity College LondonJoanne Cairns Co-InvestigatorUniversity of HullSally Benton Co-Investigator Royal Surrey County Hospital NHS Foundation Trust Peter Hall Co-InvestigatorUniversity of EdinburghRobert LoganCo-InvestigatorKings College Hospital NHS Foundation Trust Farhat Din Co-Investigator University of Edinburgh Robert Steele Co-Investigator Angela Niven Project ManagerUniversity of EdinburghMaheva Vallet Data Manager University of Edinburgh Dharmishta Parmar Senior Data ManagerQueen Mary University of LondonJoy LiStatisticianQueen Mary University of LondonHannah Miles Qualitative ResearcherUniversity of HullChloe Thomas Research FellowUniversity of SheffieldYuxiao Sun Research AssistantUniversity of SheffieldJazzine Smith Research Fellow University College London Saskia Sanderson Collaborator University College London Juliet Usher Smith Professor of General PracticeUniversity of CambridgeBecky Dennison Research AssociateUniversity of Cambridge Lily Taylor Research Assistant University of Cambridge James Kang PhD Student University of Cambridge Judith Strachan Consultant Clinical Scientist Scottish Bowel Screening Centre Stephen Rowley PPI Lead/Co-Applicant Contact Details bowel.star.uk@ed.ac.uk Key Collaborations Queen Mary University of London (QMUL) University of Dundee Institute of Cancer Research University of Sheffield University College London University of Cambridge University of Hull Kings College Hospital NHS Foundation Trust Royal Surrey County Hospital NHS Foundation Trust Kings College London Scottish Bowel Screening Centre Funders Cancer Research UK Timeline Start date: May 2024 End date: April 2029 Scientific themes Stratification | Bowel Cancer | Risk-stratified | Faecal Immunochemical Test (FIT) | Adenomas | Colorectal Cancer | Polygenic risk scores | Personal Bowel Cancer Risk (PBCR) | Modelling | Bowel cancer screening | FIT thresholds Methodology keywords Cohort Study | Horizon scanning | Health Economic modelling | Empirical modelling | Micro-simulation modelling | PRS testing | Qualitative | Patient experiences | Semi-Structured Interviews | Questionnaire | NVivo This article was published on 2024-11-15